Edges in Network
| Network | GSE25066_top8000 - GSE25066 - SiGN-BN NNSR |
| Network Description | Genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer |
| Node | SPARCL1 |
| Upstream (Parents) |
|---|
| (<<) DCN → SPARCL1 |
| (<<) HTRA1 → SPARCL1 |
| Downstream (Children) |
|---|
| SPARCL1 → SOBP (>>) |
| SPARCL1 → MEOX2 (>>) |
| SPARCL1 → NR2F1 (>>) |
| SPARCL1 → FRZB (>>) |
| SPARCL1 → OGN (>>) |
| SPARCL1 → CAV1 (>>) |
| SPARCL1 → DARC (>>) |
| SPARCL1 → NEFH (>>) |
| SPARCL1 → CDH5 (>>) |
| SPARCL1 → PCSK5 (>>) |
| SPARCL1 → PTN (>>) |
| SPARCL1 → EMCN (>>) |
| SPARCL1 → RUNX1T1 (>>) |
| SPARCL1 → DST (>>) |
| SPARCL1 → ABCA8 (>>) |
| SPARCL1 → IL33 (>>) |
| SPARCL1 → IGF1 (>>) |
| SPARCL1 → C7 (>>) |
| SPARCL1 → MECOM (>>) |
| SPARCL1 → LHFP (>>) |
| SPARCL1 → CCL15///CCL14 (>>) |
| SPARCL1 → LDB2 (>>) |
| SPARCL1 → COL14A1 (>>) |
| SPARCL1 → MAB21L1 (>>) |
| SPARCL1 → THSD7A (>>) |
| SPARCL1 → AOX1 (>>) |
| SPARCL1 → A2M (>>) |
| SPARCL1 → PALMD (>>) |
| SPARCL1 → FMO3 (>>) |
| SPARCL1 → L2HGDH (>>) |
| SPARCL1 → MMRN1 (>>) |
| SPARCL1 → AKAP12 (>>) |
| SPARCL1 → CLDN18 (>>) |
| SPARCL1 → FGF1 (>>) |
| SPARCL1 → CD93 (>>) |
| SPARCL1 → COL17A1 (>>) |
| SPARCL1 → MEIS2 (>>) |
| SPARCL1 → AQP1 (>>) |
| SPARCL1 → FGF6 (>>) |
| SPARCL1 → THBS4 (>>) |
| SPARCL1 → INS-IGF2///IGF2 (>>) |
| SPARCL1 → MATN2 (>>) |
| SPARCL1 → TICAM1 (>>) |
| SPARCL1 → MMP23A///MMP23B (>>) |
| SPARCL1 → ERG (>>) |
| SPARCL1 → PDE2A (>>) |
| SPARCL1 → ARHGAP6 (>>) |
| SPARCL1 → AOC3 (>>) |
| SPARCL1 → TGFBR3 (>>) |
| SPARCL1 → MEST (>>) |
| SPARCL1 → ECM2 (>>) |
| SPARCL1 → PPAP2A (>>) |
| SPARCL1 → CILP (>>) |
| SPARCL1 → FXYD1 (>>) |
| SPARCL1 → SLIT2 (>>) |
| SPARCL1 → JAM2 (>>) |
| SPARCL1 → LTBP2 (>>) |
| SPARCL1 → SOX17 (>>) |
